The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

NCT05438875 PHASE3 COMPLETED

A Prospective, Randomized, Open-Label, Multicenter Clinical Trial study to compare the efficacy and safety of ATRA plus eltrombopag compared to eltrombopag monotherapy in the treatment of steroid-resistant/relapsed immune thrombocytopenia (ITP).

Details

Lead sponsor	Peking University People's Hospital
Phase	PHASE3
Status	COMPLETED
Enrolment	96
Start date	Wed Oct 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Nov 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Purpura, Thrombocytopenic, Idiopathic

Interventions

• all-trans retinoic acid
• Eltrombopag

Countries

China